Crewe Advisors LLC
- SEC CIK
- 0001730033
- Latest filing
- Jul 23, 2026
DNA holding history
Ginkgo Bioworks Holdings, Inc. in every 13F filed by Crewe Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DNA overviewAll 13F holders of DNAFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −5,000−100.0% | Sold out | Holders |
| Q2 2023 | 5,000 | $9.30K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 5,000 | $6.65K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 5,000 | $8.45K | <0.1% | −400−7.4% | Reduced | Holders |
| Q3 2022 | 5,400 | $17.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 5,400 | $13.0K | <0.1% | +5,000+1,250.0% | Added | Holders |
| Q1 2022 | 400 | $2.00K | <0.1% | +400 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −400−100.0% | Sold out | Holders |
| Q3 2021 | 400 | $5.00K | <0.1% | +400 | New | Holders |